In addition, UCA1 silencing reduced SN neuron apoptosis and oxidative stress, and improved neuroinflammation in rats with PD by inhibiting the activation of the phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway [143]. Here, AKT1 is linked to Parkinson disease.